Related Experiment Videos
[Prostatic cancer: an expensive dilemma]
M Borre1, B Nerstrøm, J Overgaard
1Arhus Kommunehospital, Kraeftens Bekaempelses afdeling for eksperimentel klinisk onkologi.
Ugeskrift for Laeger
|April 21, 1997
Summary
Prostate cancer palliative care significantly burdens Danish healthcare, costing 0.72% of the national health budget in 1995. This highlights the need for better prognostic factors and treatment strategies for prostate cancer patients.
Area of Science:
- Oncology
- Health Economics
- Public Health
Context:
- Prostate cancer treatment is becoming more aggressive without effective prognostic factors.
- There is a dramatic increase in prostate cancer incidence in Denmark.
- Palliative care for prostate cancer patients requires substantial hospital resources.
Purpose:
- To describe the rising human suffering and healthcare costs associated with prostate cancer palliative treatment in Denmark.
- To analyze the financial impact of prostate cancer palliative care on the Danish National Health Budget.
Summary:
- A retrospective study analyzed 719 prostate cancer patients in Aarhus County (1979-1983).
- Data from hospital records and death certificates were used to estimate costs.
- Calculations indicate that Danish hospital expenses for prostate cancer palliative treatment reached 0.72% of the total National Health Budget in 1995.
Impact:
- The study underscores the significant economic burden of prostate cancer palliative care.
- Findings suggest a need for improved prognostic factors to optimize treatment and resource allocation.
- Highlights the considerable demand for hospital care and palliative treatment throughout the patient journey.